Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Reiss

Showing results (491-500 of 509) with videos related to

Pageof 51
Sort By:
Plos Medicine|October 19, 2013
Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)Amanda Mocroft, Jens D Lundgren, Miriam Lewis Sabin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2017
Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or OlderSara Lodi, Dominique Costagliola, Caroline Sabin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2017
The Human Immunodeficiency Virus Continuum of Care in European Union Countries in 2013: Data and ChallengesAnnabelle Gourlay, Teymur Noori, Anastasia Pharris, et al.
Science (New York, N.Y.)|February 3, 2022
A highly virulent variant of HIV-1 circulating in the NetherlandsChris Wymant, Daniela Bezemer, François Blanquart, et al.
The Lancet. HIV|November 3, 2023
Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: an emulation of target trials in the HIV-CAUSAL Collaboration and the Antiretroviral Therapy Cohort CollaborationSophia M Rein, Sara Lodi, Roger W Logan, et al.
Virus Evolution|December 10, 2025
The genetic architecture of HIV-1 virulenceFrançois Blanquart, Chris Wymant, Matthew Hall, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2023
Early Antiretroviral Therapy Not Associated With Higher Cryptococcal Meningitis Mortality in People With Human Immunodeficiency Virus in High-Income Countries: An International Collaborative Cohort StudySuzanne M Ingle, Jose M Miro, Margaret T May, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 20, 2016
When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational StudyEllen C Caniglia, Caroline Sabin, James M Robins, et al.
Archives of Internal Medicine|March 10, 2010
Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years, Rebecca Lodwick, Dominique Costagliola, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 25, 2014
Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recoveryFrederik N Engsig, Robert Zangerle, Olga Katsarou, et al.
Pageof 51

Showing results (491-500 of 509) with videos related to

Sort By:
Pageof 51
Plos Medicine|October 19, 2013
Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)Amanda Mocroft, Jens D Lundgren, Miriam Lewis Sabin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2017
Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or OlderSara Lodi, Dominique Costagliola, Caroline Sabin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2017
The Human Immunodeficiency Virus Continuum of Care in European Union Countries in 2013: Data and ChallengesAnnabelle Gourlay, Teymur Noori, Anastasia Pharris, et al.
Science (New York, N.Y.)|February 3, 2022
A highly virulent variant of HIV-1 circulating in the NetherlandsChris Wymant, Daniela Bezemer, François Blanquart, et al.
The Lancet. HIV|November 3, 2023
Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: an emulation of target trials in the HIV-CAUSAL Collaboration and the Antiretroviral Therapy Cohort CollaborationSophia M Rein, Sara Lodi, Roger W Logan, et al.
Virus Evolution|December 10, 2025
The genetic architecture of HIV-1 virulenceFrançois Blanquart, Chris Wymant, Matthew Hall, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2023
Early Antiretroviral Therapy Not Associated With Higher Cryptococcal Meningitis Mortality in People With Human Immunodeficiency Virus in High-Income Countries: An International Collaborative Cohort StudySuzanne M Ingle, Jose M Miro, Margaret T May, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 20, 2016
When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational StudyEllen C Caniglia, Caroline Sabin, James M Robins, et al.
Archives of Internal Medicine|March 10, 2010
Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years, Rebecca Lodwick, Dominique Costagliola, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 25, 2014
Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recoveryFrederik N Engsig, Robert Zangerle, Olga Katsarou, et al.
Pageof 51